
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Yin and Yang of Discoidin Domain Receptors (DDRs): Implications in Tumor Growth and Metastasis Development
Sandra Majo, Patrick Auguste
Cancers (2021) Vol. 13, Iss. 7, pp. 1725-1725
Open Access | Times Cited: 26
Sandra Majo, Patrick Auguste
Cancers (2021) Vol. 13, Iss. 7, pp. 1725-1725
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 296
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 296
The Functional Role of Extracellular Matrix Proteins in Cancer
N. V. Popova, Manfred Jücker
Cancers (2022) Vol. 14, Iss. 1, pp. 238-238
Open Access | Times Cited: 169
N. V. Popova, Manfred Jücker
Cancers (2022) Vol. 14, Iss. 1, pp. 238-238
Open Access | Times Cited: 169
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
Ahmed Elkamhawy, Qili Lu, Hossam Nada, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6535-6535
Open Access | Times Cited: 73
Ahmed Elkamhawy, Qili Lu, Hossam Nada, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6535-6535
Open Access | Times Cited: 73
Extracellular Matrix Dynamics as an Emerging yet Understudied Hallmark of Aging and Longevity
Cyril Statzer, Ji Young Cecilia Park, Collin Y. Ewald
Aging and Disease (2023) Vol. 14, Iss. 3, pp. 670-670
Open Access | Times Cited: 40
Cyril Statzer, Ji Young Cecilia Park, Collin Y. Ewald
Aging and Disease (2023) Vol. 14, Iss. 3, pp. 670-670
Open Access | Times Cited: 40
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
Dallas B. Flies, Solomon Langermann, Christina Jensen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Dallas B. Flies, Solomon Langermann, Christina Jensen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer
Junquan Liu, Huai-Chin Chiang, Wei Xiong, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006720-e006720
Open Access | Times Cited: 28
Junquan Liu, Huai-Chin Chiang, Wei Xiong, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006720-e006720
Open Access | Times Cited: 28
Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer
Li Chen, Xiangyi Kong, Yi Fang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33
Li Chen, Xiangyi Kong, Yi Fang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33
The role of network‐forming collagens in cancer progression
Jin Zhang, Jieya Liu, Hongying Zhang, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 6, pp. 833-842
Closed Access | Times Cited: 23
Jin Zhang, Jieya Liu, Hongying Zhang, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 6, pp. 833-842
Closed Access | Times Cited: 23
Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR)
Rohit Pal, B. Kumaraswamy, S. K. Md. Ashadul, et al.
ChemistrySelect (2024) Vol. 9, Iss. 30
Closed Access | Times Cited: 5
Rohit Pal, B. Kumaraswamy, S. K. Md. Ashadul, et al.
ChemistrySelect (2024) Vol. 9, Iss. 30
Closed Access | Times Cited: 5
Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes
Hongfan Zhao, Zihao Chen, Yunze Fang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 21
Hongfan Zhao, Zihao Chen, Yunze Fang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 21
Research progress of DDR1 inhibitors in the treatment of multiple human diseases
Mengying Liu, Jifa Zhang, Xiaoxue Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116291-116291
Closed Access | Times Cited: 4
Mengying Liu, Jifa Zhang, Xiaoxue Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116291-116291
Closed Access | Times Cited: 4
Discoid Domain Receptors Signaling in Macrophages-Mediated Diseases
Yaohui Ma, Hang Gong, Long Cheng, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 907-926
Open Access
Yaohui Ma, Hang Gong, Long Cheng, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 907-926
Open Access
Optimized zymogram protocol from 3D spheroid cultures to study MMP-2 and -9 activities in tumor cells
Sandra Majo, Chloe Redoute-Timonnier, A. Lacour, et al.
BMC Biotechnology (2025) Vol. 25, Iss. 1
Open Access
Sandra Majo, Chloe Redoute-Timonnier, A. Lacour, et al.
BMC Biotechnology (2025) Vol. 25, Iss. 1
Open Access
ECM, integrins, and DDRs: A nexus of cancer progression, therapy, and future directions
M A Azim, Julie S. Di Martino
Matrix Biology (2025) Vol. 138, pp. 27-43
Closed Access
M A Azim, Julie S. Di Martino
Matrix Biology (2025) Vol. 138, pp. 27-43
Closed Access
New target DDR1: A “double-edged sword” in solid tumors
Yonggang Tian, Feihu Bai, Dekui Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188829-188829
Closed Access | Times Cited: 16
Yonggang Tian, Feihu Bai, Dekui Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188829-188829
Closed Access | Times Cited: 16
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins
Angela M. Schab, Molly M. Greenwade, Elizabeth Stock, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 11, pp. 1234-1248
Closed Access | Times Cited: 9
Angela M. Schab, Molly M. Greenwade, Elizabeth Stock, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 11, pp. 1234-1248
Closed Access | Times Cited: 9
Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma
Kshama Gupta, Jeremy Jones, Virgínea Farias, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Kshama Gupta, Jeremy Jones, Virgínea Farias, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Discoidin domain receptors; an ancient family of collagen receptors has major roles in bone development, regeneration and metabolism
Renny T. Franceschi, Shawn A. Hallett, Chunxi Ge
Frontiers in Dental Medicine (2023) Vol. 4
Open Access | Times Cited: 5
Renny T. Franceschi, Shawn A. Hallett, Chunxi Ge
Frontiers in Dental Medicine (2023) Vol. 4
Open Access | Times Cited: 5
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
Anbu Liu, Shaoting Zhang, Ming Wang, et al.
Molecular Carcinogenesis (2023) Vol. 63, Iss. 1, pp. 75-93
Closed Access | Times Cited: 5
Anbu Liu, Shaoting Zhang, Ming Wang, et al.
Molecular Carcinogenesis (2023) Vol. 63, Iss. 1, pp. 75-93
Closed Access | Times Cited: 5
Implication of the Extracellular Matrix in Metastatic Tumor Cell Dormancy
Chloe Redoute-Timonnier, Patrick Auguste
Cancers (2024) Vol. 16, Iss. 23, pp. 4076-4076
Open Access | Times Cited: 1
Chloe Redoute-Timonnier, Patrick Auguste
Cancers (2024) Vol. 16, Iss. 23, pp. 4076-4076
Open Access | Times Cited: 1
Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell Phenotype
Charles Saby, Erik Maquoi, Frédéric Saltel, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 4
Charles Saby, Erik Maquoi, Frédéric Saltel, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 4
Evaluation of t-DARPP Expression Alteration in Association with DDR1 Expression in Non-Small Cell Lung Cancer
Zahra Damavandi, Pardis Riahi, Tayebeh Majidizadeh, et al.
Deleted Journal (2024) Vol. 28, Iss. 1, pp. 23-30
Open Access
Zahra Damavandi, Pardis Riahi, Tayebeh Majidizadeh, et al.
Deleted Journal (2024) Vol. 28, Iss. 1, pp. 23-30
Open Access
Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma
Ying Xu, Hangbin Jin, Yan Chen, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access
Ying Xu, Hangbin Jin, Yan Chen, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access
Discoidin domain receptor 1 may be involved in biological barrier homeostasis
Xiaoli Li, Huiling Chen, Dekui Zhang
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 12, pp. 2397-2407
Closed Access | Times Cited: 2
Xiaoli Li, Huiling Chen, Dekui Zhang
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 12, pp. 2397-2407
Closed Access | Times Cited: 2